Page last updated: 2024-09-04

carbapenems and doripenem

carbapenems has been researched along with doripenem in 327 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(doripenem)
Trials
(doripenem)
Recent Studies (post-2010) (doripenem)
7,3551475,27740433235

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)doripenem (IC50)
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)1.9953

Research

Studies (327)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (1.22)18.2507
2000's102 (31.19)29.6817
2010's211 (64.53)24.3611
2020's10 (3.06)2.80

Authors

AuthorsStudies
Irie, T; Iso, Y; Motokawa, K; Nishino, Y; Nishitani, Y1
Irie, T; Iso, Y; Iwaki, T; Kii, M; Motokawa, K; Nishitani, Y; Sendo, Y1
Hikida, M; Mitsuhashi, S; Mori, M; Nasu, T; Nishihara, T1
Ishii, Y; Miyazaki, S; Ohno, A; Tsuji, M; Yamaguchi, K1
Hayasaki, Y; Hua, YX; Izumi, K; Mikamo, H; Sato, Y; Tamaya, T1
Nagayama, A; Nomura, S1
Ge, Y; Livermore, DM; Mushtaq, S2
Blosser-Middleton, RS; Ge, Y; Karlowsky, JA; Sahm, DF; Wikler, MA1
Biedenbach, DJ; Fritsche, TR; Huynh, HK; Jones, RN; Sader, HS1
Biedenbach, DJ; Huynh, HK; Jones, RN2
Brown, SD; Traczewski, MM2
Fritsche, TR; Jones, RN; Sader, HS1
Lynch, AS1
Chen, Y; Garber, E; Ge, Y; Kaniga, K; Saiman, L; Wikler, MA; Zhao, Q1
Ambrose, PG; Bhavnani, SM; Cirincione, BB; Hammel, JP; Wikler, MA1
Bradley, D1
Engel, AE; Glass, D; Li, C; Wexler, HM1
Kobayashi, Y1
Fritsche, TR; Jones, RN; Stilwell, MG1
Inamatsu, K; Saito, A; Shiba, T; Shimada, J; Shuden, S; Yamaguchi, K; Yokoyama, T1
Abe, K; Arai, T; Hasebe, N; Horiuchi, M; Kimura, M; Tokumura, M1
Fujimoto, S; Ike, Y; Sakyo, S; Tanimoto, K; Tomita, H1
Anderson, DL1
Rice, LB1
Fujimura, T; Miwa, H; Nishikawa, T; Tsuji, M; Yamano, Y; Yutsudou, T1
Nicolau, DP; Sutherland, C1
Dilay, L; Hoban, DJ; Karlowsky, JA; Noreddin, AM; Rubinstein, E; Thomson, K; Wiebe, R; Zhanel, GG1
Katsube, T; Yamano, Y; Yano, Y1
Weigelt, JA1
Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T; Urakawa, N1
Lister, PD1
Appelbaum, PC; Credito, KL; Ednie, LM1
Fritsche, TR; Janechek, MJ; Jones, RN; Sader, HS1
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA1
Nicolau, DP1
Bush, K; Davies, TA; Flamm, RK; Shang, W2
Joseph, J; Rodvold, KA1
Ikawa, K; Ikeda, K; Kameda, K; Morikawa, N; Ohge, H; Sueda, T; Urakawa, N1
Giamarellou, H; Kanellakopoulou, K1
Chastre, J; Friedland, I; Kaniga, K; Lee, M; Prokocimer, P; Wunderink, R1
Gilbert, D1
Kobayashi, Y; Sumitani, Y1
Giamarellou, H; Poulakou, G2
Banevicius, MA; Kim, A; Nicolau, DP1
Friedland, I; Gast, C; Ingham, M; Ketter, N; Lee, M; Merchant, S; Nathwani, D; Quintana, A1
Friedland, I; Kaniga, K; Ketter, N; Lee, M; Lobo, SM; Niederman, M; Prokocimer, P; Réa-Neto, A; Schroeder, E1
Friedland, I; Jasovich, A; Jiang, J; Kaniga, K; Lucasti, C; Umeh, O1
Brammer, MK; Chan, P; Gilmor, T; Heatherly, K; Kupiec, TC; Psathas, PA; Schaufelberger, D; Trissel, LA; Trusley, C1
Hussar, DA1
Cirillo, I; Cuyckens, F; Desai-Krieger, D; Devineni, D; Janssen, C; Kao, LM; Mannens, G; Redman, R; Turner, K; Vaccaro, N; Vermeir, M1
Chimura, T; Hirayama, T; Murayama, K; Numazaki, M; Ogawa, H1
Fujimoto, S; Ike, Y; Okuzumi, K; Tanimoto, K; Tomita, H1
Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T1
Hedge, DD1
Keam, SJ1
Brown, NP; Pillar, CM; Sahm, DF; Shah, D; Torres, MK1
Jacobus, NV; McDermott, LA; Snydman, DR1
Goto, T; Ichiishi, T; Mikamo, H; Nakao, K; Tanaka, K; Watanabe, K; Yamagishi, Y1
Alba, V; Marti, S; Sánchez-Céspedes, J; Vila, J1
Porath, AD1
French, GL1
Honda, N; Ikawa, K; Kumon, H; Monden, K; Morikawa, N; Uehara, S; Yamada, Y1
Ikeda, K; Kuzmission, A; Psathas, PA; Yasuo, S1
Goff, DA; Mangino, JE; Schafer, JJ1
Naber, KG; Redman, R; Wagenlehner, C; Wagenlehner, FM; Weidner, W1
Micek, ST; Neuner, EA; Ritchie, DJ1
Lancaster, JW; Matthews, SJ1
Bell, JM; Mendes, RE; Rhomberg, PR; Sader, HS; Turnidge, JD1
Citron, DM; Goldstein, EJ1
Castanheira, M; Jones, RN; Livermore, DM1
Ambrose, PG; Andes, DR; Bhavnani, SM; Van Wart, SA1
Bell, JM; Jones, RN; Sader, HS; Stilwell, MG; Turnidge, JD1
Fritsche, TR; Jones, RN; Sader, HS; Stillwell, MG1
Livermore, DM1
Thamlikitkul, V; Trakulsomboon, S1
Cleveland, KO; Gelfand, MS; Mazumder, SA1
Esterly, JS; Malczynski, M; Postelnick, M; Qi, C; Scheetz, MH1
Bito, T; Fukamachi, S; Nakamura, M; Sawada, Y; Sugita, K; Tokura, Y1
Dedhia, HV; McKnight, R1
Depestel, DD; Paterson, DL1
Cirillo, I; Natarajan, J; Redman, R; Solanki, B; Turner, K; Vaccaro, N1
Hedrich, D; Kaniga, K; Kotey, P; Llorens, L; Naber, KG; Redman, R1
Mandell, L1
Sahm, D1
Restrepo, MI1
File, TM; Redman, R1
Amin, A1
Rahal, JJ1
Friedland, I; Ketter, N; Redman, R; Rubinstein, E; Zhanel, GG1
Kawamura, H; Matsumoto, K; Miyanohara, H; Nishi, J; Orita, M; Shigemi, A; Shimodozono, Y; Takeda, Y; Tokuda, K; Yaji, K; Yamada, K1
Anan, N; Fujimura, T; Jinushi, Y; Sugimori, G; Watanabe, T; Yamano, Y; Yoshida, I1
Bulik, CC; Crandon, JL; Nicolau, DP1
Fisher, AC; Jenkins, SG; Kaniga, K; Nicholson, SC; Peterson, JA1
Guery, BP1
Bush, K; Flamm, R; Queenan, AM; Shang, W1
Akhras, K; Caro, JJ; Kongnakorn, T; Merchant, S; Mwamburi, M; Nathwani, D1
Katsube, T; Takano, M; Wajima, T; Yamano, Y; Yano, Y1
Bonomo, RA; Karpen, ME; Leonard, DA; Powers, RA; Schneider, KD1
Danishuddin, M; Khan, AU; Shakil, S1
Cattoir, V; Daurel, C1
Goto, K; Hagiwara, S; Hidaka, S; Iwasaka, H; Noguchi, T1
Overturf, GD1
Akhras, K; DeLong, K; Ingham, M; McGarry, LJ; Merchant, S; Nathwani, D; Pawar, V; Thompson, D; Weinstein, MC1
Berthoin, K; Carryn, S; Le Duff, CS; Marchand-Brynaert, J; Tulkens, PM1
Hibi, H; Honda, N; Ikawa, K; Ikeda, K; Mitsui, K; Morikawa, N; Nakamura, K; Narushima, M; Yamada, Y1
Goossens, H; Ieven, M; Jansens, H; Naesens, R; Vlieghe, E1
Bogiel, T; Deptuła, A; Gospodarek, E1
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY1
Bied, A; Brown, D; Bush, K; Drusano, GL; Fregeau, C; Kahn, JB; Khashab, M; Kulawy, R; Liu, W; Louie, A; Morrow, B; Nicholson, S; Queenan, AM; Van Scoy, B1
Appelbaum, PC; Credito, K; Kosowska-Shick, K1
Esterly, JS; Malczynski, M; Qi, C; Scheetz, MH1
Blanchard, JS; Fan, F; Tremblay, LW1
Mariano, N; Rahal, JJ; Urban, C1
Lin, R; Nandy, P; Samtani, MN1
Flamm, R; Kaniga, K; Nandy, P; Samtani, MN1
Gast, C; Ketter, N; Kollef, MH; Merchant, S; Nathwani, D; Quintana, A1
Hope, R; Livermore, DM; Pllana, T; Warner, M1
Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Picazo, JJ; Rodríguez-Avial, I1
Dubreuil, L; Jean-Pierre, H; Mahieux, S; Marchandin, H; Miara, A; Muller-Serieys, C; Neut, C; Soussy, CJ1
Amsler, K; Bush, K; Flamm, R; Foleno, B; Santoro, C1
Elborn, JS; Parkins, MD1
Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY1
Cielecka-Piontek, J; Jelińska, A1
Bulik, CC; Nicolau, DP1
Chen, J; Mody, SH; Shorr, AF; Zilberberg, MD1
Mazzei, T1
Crandon, JL; Keel, RA; Nicolau, DP; Sutherland, CA1
Araújo, C; Gonçalves, A; Igrejas, G; Poeta, P; Radhouani, H; Rodrigues, J; Silva, N1
Crandon, JL; Nicolau, DP; Sutherland, C1
Cantón, R; García, A; Gimeno, C; Gobernado, M1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D1
Cassettari, M; Chongthaleong, A; Christiansen, KJ; Cooper, D; Flamm, R; Garcia, J; Hsu, L; Ip, M; Ker, HB; Kiratisin, P; Mendoza, M; Morrissey, I; Okolo, P; Quintana, A; Redjeki, IS1
Ko, KS; Lee, H; Peck, KR; Song, JH1
Araki, N; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamada, Y; Yanagihara, K1
Apisarnthanarak, A; Mundy, LM2
Buron, JA; Cerrato, SG; Garau, J; Rello, J; Rodriguez, JA; Rossolini, GM; Zaragoza, R1
Armand-Lefevre, L; Drugeon, HB; Gjoklaj, M; Kitzis, MD; Lascols, C; Leclercq, R; Legrand, P; Lemire, A; Mérens, A; Miara, A; Moubareck, C; Muller-Serieys, C; Reverdy, ME; Roussel-Delvallez, M; Soussy, CJ1
Chahine, EB; Ferrill, MJ; Poulakos, MN1
Aguado, JM1
Abbanat, D; Barron, A; Bunting, RA; Fernandez, J; Flamm, RK; Hall, L; Hilliard, JJ; Lynch, AS; Melton, JL; Ward, CK1
Wilke, MH1
Gomersall, C; Kuti, JL; Kwa, A; Montakantikul, P; Nicolau, DP; Roberts, JA1
Gautam, V; Kaur, M; Ray, P; Singhal, L1
Balis, D; Cirillo, I; Matzke, GR; Redman, R; Vaccaro, N1
Bonomo, RA; Leonard, DA; Ortega, CJ; Powers, RA; Renck, NA; Schneider, KD1
Chapman, BA; Hellwig, TR; Onisk, ML1
Appelbaum, PC; Armstrong, ES; Kosowska-Shick, K; Kubo, A; Lin, G; Pankuch, GA1
Michalska, K; Pajchel, G; Tyski, S1
Damiao, R; Davies, T; Kaniga, K; Kotey, P; Naber, KG; Redman, R1
Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C1
Chen, YH; Hsueh, PR; Huang, YT; Ko, WC; Lai, CC; Liu, WL; Tan, HR1
Flamm, RK; Korten, V; Laeuffer, JM; Morrissey, I; Mutters, R; Nordmann, P; Picazo, JJ; Quintana, A; Seak, JC1
Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM1
Engler, C; Harris, P; Norton, R1
Goessens, WH; Mol, M; Pitout, JD; van der Bij, AK; van Westreenen, M1
Archontaki, H; Boutos, N; Charkoftaki, G; Dimaraki, E; Margetis, K; Markantonis, S; Sakas, DE; Skoutelis, A; Valsami, G; Vryonis, E1
Hirata, S; Kadowaki, D; Nishi, K; Tanoue, K1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN1
Cabot, G; Cantón, R; del Campo, R; García-Castillo, M; Juan, C; Mulet, X; Oliver, A; Riera, E1
Amsler, K; Davies, TA; Flamm, RK; He, W; Lynch, AS; Marie Queenan, A; Morrow, BJ; Pillar, C; Shang, W1
Akers, KS; Beckius, ML; Calvano, T; Hospenthal, DR; Markelz, AE; Mende, K; Murray, CK; Yu, X; Zera, WC1
Baek, JY; Kang, CI; Ko, KS; Peck, KR; Song, JH1
Bonomo, RA; Endimiani, A; Papp-Wallace, KM; Taracila, MA1
Abe, T; Goto, K; Hagiwara, S; Hidaka, S; Nishida, T; Noguchi, T; Ohchi, Y; Shitomi, R; Yamamoto, S; Yasuda, N1
Bergen, PJ; Bulitta, JB; Forrest, A; Jacob, J; Li, J; Nation, RL; Paterson, DL; Sidjabat, HE; Tsuji, BT1
Balderson, BJ; Patil, NP; Suda, KJ; Yates, ME1
Daniels, LM; Heil, EL; Nicolau, DP; Smith, EA; Walko, CM1
Anan, N; Ito, A; Nakamura, R; Toba, S; Tsuji, M1
Harada, M; Hayamizu, Y; Kurono, Y; Nagano, H; Umakoshi, M; Yoshifuku, K1
Burian, B; Donath, O; Reznicek, G; Sauermann, R; Zeitlinger, M1
Black, PL; Cirillo, I; Kearns, GL; Redman, R; Vaccaro, N1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D1
Firsov, AA; Gilbert, D; Greer, K; Portnoy, YA; Zinner, SH2
Hagihara, M; Kuti, JL; Nicolau, DP1
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G1
DE Sarro, A; Fera, MT; Zummo, S1
Botha, F; Burgmann, H; Donath, O; Illievich, UM; Müller, M; Poeppl, W; Wurm, G; Zeitlinger, M1
Cleveland, KO; Gelfand, MS1
Clancy, CJ; Jernigan, MG; Nguyen, MH; Press, EG; Shields, RK1
Antunes, NT; Frase, H; Toth, M; Vakulenko, SB; Vakulenko, V1
Archontaki, H; Boutos, N; Charkoftaki, G; Dimaraki, E; Dokoumetzidis, A; Margetis, K; Markantonis, S; Nalda-Molina, R; Sakas, D; Skoutelis, A; Valsami, G; Vryonis, E1
Chen, CC; Cheng, KC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Ku, YH; Tang, HJ; Zhang, CC1
De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA1
Adier, C; Couet, W; Goldschmidt, P; Grégoire, N; Lamarche, I; Laroche, L; Marchand, S; Semoun, O1
Arakawa, M; Honda, N; Ikawa, K; Ikeda, K; Morikawa, N; Nakamura, K; Nishikawa, G; Yamada, Y; Zennami, K1
Ichikawa, M; Kurokawa, M; Nannya, Y; Narukawa, K; Toya, T1
Inoue, K; Iwasaki, T; Takaku, K; Yamamoto, T1
Bowker, KE; Elliott, H; Macgowan, AP; Noel, AR; Tomaselli, SG1
Bergen, PJ; Bulitta, JB; Davis, K; Deris, ZZ; Forrest, A; Jacob, J; Ku, CK; Li, J; Nation, RL; Paterson, DL; Poudyal, A; Soon, RL; Tsuji, BT; Velkov, T; Yu, HH1
Dundar, D; Kasap, M; Kolayli, F; Torol, S; Vahaboglu, H1
Aeinlang, N; Jaruratanasirikul, S; Jullangkoon, M; Kositpantawong, N; Wongpoowarak, W1
Farnum, C; Havlichek, DH; Kalra, A; Kulhanek, G; Kuti, JL; Nicolau, DP; Scharmen, A; Smith, CL; Stein, GE; Tran, M1
Ito, K; Kato, H; Shibata, Y; Suzuki, K; Suzuki, T1
Kato, K; Nishikawa, T; Sakai, Y; Sugiyama, H; Takahashi, M; Tsuyuguchi, T; Yokosuka, O1
Chang, SC; Dong, SX; Wang, JT1
Keel, RA; Kiratisin, P; Nicolau, DP1
Chastre, J; Cirillo, I; Clavel, M; Kaniga, K; Kimko, H; Kollef, MH; Michiels, B; Redman, R; Restrepo, MI1
Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D1
Barszcz, B; Cielecka-Piontek, J; Lewandowska, K; Paczkowska, M1
Adamski, P; Bulanda, M; Drzewiecki, A; Sodo, A; Talaga, K1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, CM1
Akiyama, N; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A1
Lipman, J; Roberts, JA1
Dantier, C; Desarbre, E; Gebhardt, K; Hofer, B; Page, MG; Schmitt-Hoffmann, A1
van der Meer, YG; van Zanten, AR1
Forrest, A; Ly, NS; Rao, G; Soon, RL; Tsuji, B; Wollenberg, L; Yang, K1
Kaniga, K; Lee, M; Redman, R; Rice, DA1
Ambe, LA; Casella, LG; Doi, Y; Ernst, RK; O'Hara, JA; Pelletier, MR; Shanks, RM; Townsend, BM1
Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, C1
Burgmann, H; Lingscheid, T; Mitteregger, D; Poeppl, W; Tobudic, S1
Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M1
Bhalodi, AA; Keel, RA; Kuti, JL; Lodise, TP; Nicolau, DP; Quintiliani, R1
Ito, A; Nakamura, R; Ohta, M; Toba, S; Tsuji, M1
Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S1
Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L1
Kemper, AL; Young, DC; Zobell, JT1
Chida, K; Harada, M; Inui, N; Matsuo, Y; Nakamura, Y; Suda, T; Wajima, T1
Hagihara, M; Housman, ST; Kuti, JL; Nicolau, DP1
Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE3
Davies, TA; He, W; Lynch, AS; Queenan, AM1
Goff, DA; Nicolau, DP1
Guzek, A; Korzeniewski, K; Nitsch-Osuch, A; Prokop, E; Rybicki, Z1
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Shimojima, M; Tada, T1
Bonomo, RA; June, CM; Kaitany, KC; Klinger, NV; Leonard, DA; Powers, RA; Ramey, ME1
Erdogan-Yildirim, Z; Manafi, M; Sauermann, R; Schwameis, R; Strommer, S; Zeitlinger, MA1
Chen, L; Cheng, S; Clancy, CJ; Doi, Y; Farrell, AN; Hao, B; Hong, JH; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK; Zhao, Y1
Kurtinecz, M; Li, G; Mitrani-Gold, FS; Mundy, LM; Singh, KP; Tomayko, JF; Wetherington, J1
Arthur, M; Cordillot, M; Dubée, V; Dubost, L; Hugonnet, JE; Mainardi, JL; Marie, A; Triboulet, S1
Casari, E; Ferrario, A; Morelli, P; Piazza, A; Tordato, F1
Taylor, B; Taylor, SP1
Clancy, CJ; Doi, Y; Nguyen, MH; O'Hara, JA; Oleksiuk, LM; Press, EG; Shields, RK; Updike, CL1
Cheatham, SC; Chung, EK; Fleming, MR; Juenke, JM; Kays, MB1
Aubry, A; Bréchot, N; Brisson, H; Brossier, F; Chastre, J; Combes, A; Jarlier, V; Lu, Q; Luyt, CE; Micaelo, M; Rouby, JJ; Trouillet, JL1
Hagiwara, K; Hirama, T; Kanazawa, M; Kawana, H; Kawashima, A; Masumoto, A; Mio, T; Nagata, M; Shiono, A1
Chen, L; Clancy, CJ; Hao, B; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK1
Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N1
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Tada, T1
Cannon, JP; Clark, NM; Grim, SA; Lee, TA; Setlak, P1
Fujita, T; Hata, H; Hieda, M; Hori, Y; Kobayashi, J; Murata, Y; Nakajima, S; Nakatani, T; Sata, M; Sato, T; Seguchi, O; Sunami, H; Wada, K; Watanabe, T; Yanase, M1
Igarashi, Y; Inui, K; Ohara, H; Ryozawa, S; Tazuma, S; Tsuyuguchi, T1
Azumi, Y; Isaji, S; Kishiwada, M; Mizuno, S; Nobuoka, Y; Osawa, I; Sakurai, H; Tabata, M; Tanemura, A; Usui, M1
Ariza, J; Bergen, PJ; Li, J; Lora-Tamayo, J; Luo, X; Murillo, O; Nation, RL; Poudyal, A; Yu, HY1
Bulitta, JB; Dunlop, R; Hayashi, Y; Jarrett, P; Lassig-Smith, M; Lipman, J; Roberts, JA; Roberts, NA; Starr, T; Stuart, J; Udy, AA; Wallis, SC1
Abbasi, SA; Day, KM; Paterson, DL; Perry, JD; Raza, MW; Sartor, AL; Sidjabat, HE1
Colombo, V; Masciocchi, N; Palmisano, G1
Gaszynski, T; Gaszynski, W; Tokarz, A; Wieczorek, A1
Bulitta, JB; Cheah, SE; Li, J; Nation, RL1
Herodes, K; Karjagin, J; Kern, H; Kipper, K; Low, K; Metsvaht, T; Oselin, K; Standing, JF; Starkopf, J; Tamme, K1
Abe, J; Fujita, A; Hino, M; Hirose, A; Kakeya, H; Kaneko, Y; Nakaie, K; Nakamura, Y; Okada, Y; Takizawa, E; Yamada, K1
Black, DJ; Frase, H; Smith, CA; Stewart, NK; Vakulenko, SB1
Ishibashi, T; Kubota, R; Matsuo, Y; Wajima, T1
Mataraci-Kara, E; Ozbek Celik, B; Yilmaz, M1
Chen, L; Clancy, CJ; Clarke, LG; Eschenauer, GA; Kreiswirth, BN; Nguyen, MH; Potoski, BA; Press, EG; Shields, RK1
Adler, B; Aranda, J; Boyce, JD; Crane, B; Deveson Lucas, D; Harper, M; Harrison, P; Henry, R; Li, J; Li, Z; Nation, RL; Powell, D1
Hara, T; Horiyama, T; Izawa, M; Kanazawa, S; Maki, H; Sato, T; Tsuji, M; Yamaguchi, T1
Bergen, PJ; Bulitta, JB; Forrest, A; Holden, PN; Landersdorfer, CB; Li, J; Ly, NS; Nation, RL; Rao, GG; Tsuji, BT1
Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F1
Liu, W; Miao, J; Qin, YP; Shu, SQ; Wang, Y; Zhang, L; Zheng, J1
Ishibashi, T; Matsuo, Y; Shimamura, K; Wajima, T1
Ikawa, K; Ishihara, N; Isobe, T; Karino, F; Miura, K; Morikawa, N; Naora, K; Nishimura, N; Tamaki, H1
Carlson, EE; Kocaoglu, O; Tsui, HC; Winkler, ME1
Li, Y; Liu, J; Lv, Y; Xue, F; Zhang, J; Zheng, B1
Allegaert, K; Bradley, JS; Castaneda-Ruiz, B; Cirillo, I; Cossey, V; Redman, R; Vaccaro, N1
Barauskas, V; Bradley, JS; Cannavino, CR; Castaneda-Ruiz, B; Cirillo, I; Emeryk, A; Go, O; Redman, R; Senatorova, G1
Kaushik, A; Lamichhane, G; Makkar, N; Pandey, P; Parrish, N; Singh, U1
Anh, NQ; Kirikae, T; Miyoshi-Akiyama, T; Nhung, PH; Ohmagari, N; Phuong, DM; Shimada, K; Tada, T1
Anupurba, S; Banerjee, T; Filgona, J1
Ansari, M; Gilani, M; Hafeez, A; Latif, M; Munir, T; Najeeb, S; Rehman, S; Saad, N1
Abd Rahman, AN; Abdul-Aziz, MH; Lipman, J; Mat-Nor, MB; Roberts, JA; Staatz, CE; Sulaiman, H; Wallis, SC1
Garcia, CV; Mendez, AS; Paliosa, PK; Schapoval, EE; Steppe, M1
Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC1
Choi, IS; Choi, JA; Jang, SJ; Jeong, SH; Kang, SH; Kim, CM; Moon, DS; Park, G; Park, GC1
Srinivas, NR1
Fritsch, A; Jaehde, U; Jäger, W; Jilch, S; Lemmerer, R; Maier-Salamon, A; Saria, K; Thalhammer, F; Unger, M; Vossen, MG; Wenisch, JM; Zuba, C1
Asık, G; Atasoy, AR; Aykan, SB; Ciftci, IH; Karakece, E; Terzi, HA1
Ji, S; Li, C; Li, S; Liang, X; Zhang, F; Zhu, Y1
Akata, K; Ishimoto, H; Kawanami, T; Kido, T; Mukae, H; Naito, K; Nishida, C; Noguchi, S; Sakamoto, N; Yamasaki, K; Yatera, K1
Baron, C; Bulitta, JB; Bulman, ZP; Holden, PN; Li, J; Ly, NS; Rao, GG; Sutton, MD; Tsuji, BT1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Maitte, A; Potel, G1
Mirza, IA; Wali, N1
Arakawa, Y; Jin, W; Kimura, K; Kurosaki, H; Mori, S; Wachino, J; Yamaguchi, Y1
Abdollahi, A; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghalavand, Z; Ghourchian, S; Mohammadzadeh, M; Nateghi Rostami, M; Rahbar, M; Zeraati, H1
Ishihara, T; Miyazaki, M; Notani, N; Tsumura, H; Yoshiiwa, T1
Aubry, A; Chastre, J; Crandon, JL; Luyt, CE; Nicolau, DP1
Armstrong, J; Gasink, LB; Huang, X; Newell, P; Sobel, JD; Stone, GG; Wagenlehner, FM; Yates, K1
Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K1
Li, F; Li, P; Yin, Y; Zhang, Q; Zhang, Y1
Hu, YF; Liu, CP; Shih, SC; Wang, NY1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N1
June, CM; Klamer, ZL; Leonard, DA; Muckenthaler, TJ; Powers, RA; Schroder, EC; Szarecka, A; Wawrzak, Z1
Abraham, P; Chaar, M; Chester, K; Curzio, K; Huang, V; Lockwood, A; Lodise, TP; Morse, B; Pai, MP; Patka, J; Rabinovich, M; Rahbar, AJ; Salomone, J; Williams, B1
Chao, CM; Chen, CC; Chuang, YC; Huang, HL; Lai, CC; Tang, HJ1
Haruyama, S; Nakamura, M; Ohmori, S; Okada, E; Sawada, Y; Shibata, M; Yamaguchi, T; Yoshioka, M1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L1
Cheatham, SC; Chung, EK; Fleming, MR; Kays, MB1
Cancelli, F; Castaldi, D; Ciardi, MR; Cipolla, A; D'Abramo, A; D'Agostino, C; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Scorzolini, L; Vullo, V1
Goto, K; Ito, K; Itoh, H; Kaneko, T; Kurogi, S; Nonoshita, K; Ohchi, Y; Sato, Y; Suzuki, Y; Tanaka, R; Ueno, T; Yasuda, N1
Aydin, M; Bayram, S; Bozkurt, O; Genç, A; Rencüzoğullari, E1
Bonomo, RA; Harper, TM; June, CM; Leonard, DA; Powers, RA; Taracila, MA1
Aubry, A; Bréchot, N; Brossier, F; Jarlier, V; Lu, Q; Luyt, CE; Micaëlo, M; Monsel, A1
Smith, CA; Stewart, NK; Toth, M; Vakulenko, SB1
Jeyakanthan, J; Lopes, BS; Ramachandran, B1
Allison, N; Crisostomo, C; Lynch, B; Padilla, M; Quach-Cu, J; Reinke, RA1
Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N1
Eom, YB; Kim, HR1
Chang, H; Lee, CM; Lee, MC; Lu, CH; Sun, FJ; Wu, AY1
Ishaq, M; Zahra, N; Zeshan, B1
Dargahi, Z; Etemad, A; Ghasemian, E; Hashemian, M; Kaviar, VH; Lohrasbi, A; Saadh, MJ1
George Priya Doss, C; Gopikrishnan, M1
Asai, Y; Ooi, H; Sato, Y1
Hsueh, PR; Ko, WC; Lee, YL1

Reviews

39 review(s) available for carbapenems and doripenem

ArticleYear
Doripenem: S 4661.
    Drugs in R&D, 2003, Volume: 4, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Stability; Humans

2003
Doripenem.
    Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:6

    Topics: Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic

2006
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Sep-01, Volume: 43 Suppl 2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Biofilms; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline

2006
Comparative review of the carbapenems.
    Drugs, 2007, Volume: 67, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Thienamycins

2007
Empiric treatment options in the management of complicated intra-abdominal infections.
    Cleveland Clinic journal of medicine, 2007, Volume: 74 Suppl 4

    Topics: Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Doripenem; Drug Resistance, Bacterial; General Surgery; Humans; Internal Medicine; Minocycline; Peritoneal Cavity; Peritonitis; Risk Factors; Severity of Illness Index; Surgical Wound Infection; Tigecycline

2007
Carbapenems in the USA: focus on doripenem.
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins; United States

2007
Carbapenems: a potent class of antibiotics.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Molecular Structure; Structure-Activity Relationship; Thienamycins

2008
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome

2008
Current therapies for pseudomonas aeruginosa.
    Critical care clinics, 2008, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic

2008
Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens.
    Expert opinion on investigational drugs, 2008, Volume: 17, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Drug Evaluation; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Structure

2008
Doripenem: a review of its use in the treatment of bacterial infections.
    Drugs, 2008, Volume: 68, Issue:14

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Humans; Kidney Diseases; Tissue Distribution

2008
What's new and not so new on the antimicrobial horizon?
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 6

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Pyrimidines; Research

2008
Doripenem: a new addition to the carbapenem class of antimicrobials.
    Recent patents on anti-infective drug discovery, 2009, Volume: 4, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Urinary Tract Infections

2009
New antibiotics for healthcare-associated pneumonia.
    Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin

2009
Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Clinical therapeutics, 2009, Volume: 31, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests

2009
Activity of a novel carbapenem, doripenem, against anaerobic pathogens.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Humans; Microbial Sensitivity Tests; Rats

2009
Doripenem: antimicrobial profile and clinical potential.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans

2009
Doripenem: position in clinical practice.
    Expert review of anti-infective therapy, 2009, Volume: 7, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections

2009
Doripenem.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jul-15, Volume: 49, Issue:2

    Topics: Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Peritonitis; Pneumonia, Bacterial; Seizures; Urinary Tract Infections

2009
Doripenem: a new carbapenem in the treatment of nosocomial infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Overview of seizure-inducing potential of doripenem.
    Drug safety, 2009, Volume: 32, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Seizures; Young Adult

2009
Multidrug-resistant Gram-negative infections: what are the treatment options?
    Drugs, 2009, Oct-01, Volume: 69, Issue:14

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline

2009
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
    Current medical research and opinion, 2009, Volume: 25, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult

2009
[Doripenem: need for a new carbapenem].
    Medecine et maladies infectieuses, 2009, Volume: 39, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections

2009
Doripenem versus bacteria: an emerging battleground.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:5

    Topics: Animals; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans

2009
[Update on antimicrobial chemotherapy].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:3

    Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline

2010
Doripenem: an early look at a carbapenem not yet approved for pediatrics.
    The Pediatric infectious disease journal, 2010, Volume: 29, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans; Microbial Sensitivity Tests

2010
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9

    Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline

2010
The pharmacokinetics and pharmacodynamics of the carbapanemes: focus on doripenem.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Humans

2010
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitals, Teaching; Humans; Microbial Sensitivity Tests

2011
Doripenem: a new carbapenem antibiotic.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Dec-01, Volume: 67, Issue:23

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Formularies, Hospital as Topic; Humans

2010
[Role of new carbapenems in nosocomial intraabdominal infection].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28 Suppl 2

    Topics: Abdomen; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Humans; Multicenter Studies as Topic; Postoperative Complications; Pseudomonas Infections; Randomized Controlled Trials as Topic; Soft Tissue Infections

2010
Multiresistant bacteria and current therapy - the economical side of the story.
    European journal of medical research, 2010, Nov-30, Volume: 15, Issue:12

    Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Doripenem; Drug Resistance, Microbial; Drug Resistance, Multiple; Economics, Pharmaceutical; Linezolid; Minocycline; Oxazolidinones; Tigecycline

2010
Carbapenems: past, present, and future.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Anti-Bacterial Agents; beta-Alanine; beta-Lactams; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Thienamycins

2011
In vitro activity studies of doripenem and two other carbapenems tested against Pseudomonas aeruginosa and other non-fermentative bacilli.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:6

    Topics: Anti-Bacterial Agents; Bacillus; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2011
A case of Lemierre's syndrome in association with liver abscess without any other metastatic lesions.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Disseminated Intravascular Coagulation; Doripenem; Fusobacterium necrophorum; Humans; Lemierre Syndrome; Liver Abscess; Male; Ofloxacin

2012
Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Databases, Bibliographic; Doripenem; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Male; Research Design; Treatment Outcome; Urinary Tract Infections

2013
The risk of seizures among the carbapenems: a meta-analysis.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Meropenem; Risk; Seizures; Thienamycins

2014
The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis.
    The Yale journal of biology and medicine, 2022, Volume: 95, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2022

Trials

32 trial(s) available for carbapenems and doripenem

ArticleYear
Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method

2005
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
    Critical care medicine, 2008, Volume: 36, Issue:4

    Topics: Aged; Anti-Bacterial Agents; APACHE; Carbapenems; Doripenem; Female; Hospital Mortality; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Treatment Outcome

2008
"The truth, if it exists, is in the details".
    Critical care medicine, 2008, Volume: 36, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Doripenem; Humans; Imipenem; Pneumonia, Ventilator-Associated; Severity of Illness Index; Treatment Outcome

2008
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
    Clinical therapeutics, 2008, Volume: 30, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Costs and Cost Analysis; Doripenem; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospital Costs; Humans; Imipenem; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Ventilator-Associated; Survival Rate; Treatment Outcome

2008
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
    Current medical research and opinion, 2008, Volume: 24, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Tazobactam; Treatment Outcome

2008
Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Clinical therapeutics, 2008, Volume: 30, Issue:5

    Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins

2008
Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Carbon Radioisotopes; Chromatography, Liquid; Cohort Studies; Doripenem; Humans; Infusions, Intravenous; Male; Middle Aged; Safety; Tandem Mass Spectrometry

2008
[Clinical examination of doripenem for infectious diseases in gynecological and associated fields].
    The Japanese journal of antibiotics, 2008, Volume: 61, Issue:2

    Topics: Bacterial Infections; Carbapenems; Doripenem; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Treatment Outcome

2008
Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Pyelonephritis; Urinary Tract Infections

2009
Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:7

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross-Over Studies; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors

2009
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pyelonephritis; Urinary Tract Infections

2009
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult

2010
Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3

    Topics: Adult; Aged; Carbapenems; Doripenem; Hemodiafiltration; Hemofiltration; Humans; Male; Middle Aged

2011
Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:6

    Topics: Aged; Anti-Infective Agents, Urinary; Carbapenems; Doripenem; Double-Blind Method; Female; Genotype; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Urinary Tract Infections

2010
Penetration of intact blood-brain barrier by doripenem.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7

    Topics: Anti-Bacterial Agents; Blood-Brain Barrier; Carbapenems; Doripenem; Humans; Injections, Spinal

2011
Validation of doripenem dosing in patients with end-stage renal disease receiving hemodialysis.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:11

    Topics: Carbapenems; Doripenem; Female; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis

2011
Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis.
    Journal of clinical pharmacology, 2012, Volume: 52, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Young Adult

2012
A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study.
    Japanese journal of infectious diseases, 2012, Volume: 65, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Female; Fever; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Risk Factors; Thienamycins; Treatment Outcome

2012
Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors

2012
Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:10

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Neutropenia; Young Adult

2012
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.
    Critical care (London, England), 2012, Nov-13, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cilastatin; Doripenem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Ventilator-Associated; Young Adult

2012
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Critical care medicine, 2013, Volume: 41, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Monte Carlo Method; Obesity; Pneumonia, Bacterial

2013
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013
Comparative pharmacokinetics and pharmacodynamics of doripenem and meropenem in obese patients.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Gram-Negative Bacteria; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Obesity; Thienamycins

2014
Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Thienamycins

2014
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult

2014
Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.
    Journal of gastroenterology, 2015, Volume: 50, Issue:2

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Carbapenems; Cholangitis; Cholecystitis, Acute; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult

2015
Pharmacokinetics of doripenem during high volume hemodiafiltration in patients with septic shock.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Monte Carlo Method; Shock, Septic

2015
Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Doripenem; Female; Gestational Age; Half-Life; Humans; Infant; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male

2015
Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.
    The Pediatric infectious disease journal, 2015, Volume: 34, Issue:11

    Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Doripenem; Hospitalization; Humans; Infant; Intraabdominal Infections; Pneumonia, Bacterial; Treatment Outcome; Urinary Tract Infections

2015
Doripenem Treatment during Continuous Renal Replacement Therapy.
    Antimicrobial agents and chemotherapy, 2015, Dec-28, Volume: 60, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Critical Care; Doripenem; Female; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis

2015
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 09-15, Volume: 63, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Doripenem; Drug Combinations; Female; Humans; Male; Middle Aged; Pyelonephritis; Urinary Tract Infections

2016

Other Studies

256 other study(ies) available for carbapenems and doripenem

ArticleYear
A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems.
    The Journal of antibiotics, 1996, Volume: 49, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Spectrophotometry, Infrared; Structure-Activity Relationship

1996
Synthesis and modification of a novel 1 beta-methyl carbapenem antibiotic, S-4661.
    The Journal of antibiotics, 1996, Volume: 49, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship

1996
Comparative stability of carbapenem and penem antibiotics to human recombinant dehydropeptidase-I.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Dipeptidases; Doripenem; Drug Stability; Humans; Lactams; Recombinant Proteins

1996
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Doripenem; Enterobacteriaceae; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Moraxella; Penicillin Resistance; Pneumococcal Infections

1998
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Rats; Uterine Diseases

2000
In vitro antibacterial activity of S-4661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Ceftazidime; Doripenem; Humans; Imipenem; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Thienamycins; Urinary Tract Infections

2002
Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:4

    Topics: Acinetobacter; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Conjugation, Genetic; Doripenem; Enterobacteriaceae; Escherichia coli; Klebsiella; Microbial Sensitivity Tests; Plasmids

2004
In vitro antimicrobial activity of doripenem, a new carbapenem.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Cephalosporins; Doripenem; Drug Therapy, Combination; Enterobacteriaceae; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam

2004
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Culture Media; Doripenem; Enterobacteriaceae; Enterococcus; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quality Control; Respiratory Tract Infections

2004
Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Conjugation, Genetic; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections

2004
Activities of doripenem (S-4661) against drug-resistant clinical pathogens.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Resistance, Bacterial; Genotype; Gram-Negative Bacteria; Humans; Phenotype

2004
Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Carbapenems; Diffusion; Doripenem; Microbial Sensitivity Tests; Quality Control

2005
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
    Diagnostic microbiology and infectious disease, 2005, Volume: 52, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Doripenem; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests

2005
Antibacterial Drug Discovery and Development Summit - Tenth Annual SRI Summit.
    IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:5

    Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Design; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Iohexol; Macrolides; Microsomes; Minocycline; Technology, Pharmaceutical; Tigecycline

2005
In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6

    Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2005
Acquisitions not a cure for anti-infectives.
    Nature reviews. Drug discovery, 2005, Volume: 4, Issue:9

    Topics: Anidulafungin; Anti-Infective Agents; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Drug Industry; Echinocandins; Economics, Pharmaceutical; Glycopeptides; Humans; Peptides, Cyclic; Teicoplanin

2005
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Thienamycins

2005
Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005, Volume: 11, Issue:5

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2005
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:12

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Positive Cocci; Gram-Positive Rods; Humans; Microbial Sensitivity Tests; Population Surveillance; Respiratory System

2005
In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:2

    Topics: Anti-Bacterial Agents; Burkholderia cepacia; Carbapenems; Cystic Fibrosis; Doripenem; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2006
[A new carbapenem antibiotic for injection: characteristics of doripenem].
    The Japanese journal of antibiotics, 2005, Volume: 58, Issue:6

    Topics: Carbapenems; Doripenem; Humans; Injections

2005
Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.
    Toxicology, 2006, May-01, Volume: 222, Issue:1-2

    Topics: Alanine; Animals; Anti-Bacterial Agents; Anticonvulsants; Carbapenems; Convulsants; Dogs; Doripenem; Drug Interactions; Electroencephalography; Injections, Intravenous; Injections, Intraventricular; Male; Meropenem; Mice; Mice, Inbred ICR; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Thienamycins; Valproic Acid

2006
Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa isolates with doripenem plus an aminoglycoside.
    Diagnostic microbiology and infectious disease, 2006, Volume: 55, Issue:3

    Topics: Aminoglycosides; beta-Lactam Resistance; beta-Lactams; Carbapenems; Doripenem; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2006
Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.
    The Journal of antibiotics, 2006, Volume: 59, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenems; Colony Count, Microbial; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Gene Expression; Imipenem; Meropenem; Molecular Weight; Mutation; Pseudomonas aeruginosa; Thienamycins

2006
Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.
    The Journal of antibiotics, 2006, Volume: 59, Issue:12

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ceftazidime; Doripenem; Humans; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2006
Development of an HPLC method for the determination of doripenem in human and mouse serum.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Jun-15, Volume: 853, Issue:1-2

    Topics: Animals; Carbapenems; Chromatography, High Pressure Liquid; Doripenem; Humans; Mice; Reproducibility of Results

2007
Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model.
    Journal of pharmaceutical sciences, 2008, Volume: 97, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Cilastatin; Disease Models, Animal; Doripenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Models, Biological; Thienamycins

2008
Peritoneal penetration of doripenem after intravenous administration in abdominal-surgery patients.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:6

    Topics: Abdomen; Adult; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Doripenem; Exudates and Transudates; Female; Humans; Injections, Intravenous; Male; Middle Aged; Peritoneum

2007
Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysis.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Colony Count, Microbial; Doripenem; Humans; Microbial Sensitivity Tests

2008
Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem.
    Diagnostic microbiology and infectious disease, 2007, Volume: 59, Issue:4

    Topics: Anti-Bacterial Agents; Biomarkers; Carbapenems; Doripenem; Drug Approval; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxacillin; United States; United States Food and Drug Administration

2007
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests

2008
Doripenem (Doribax)--a new parenteral carbapenem.
    The Medical letter on drugs and therapeutics, 2008, Jan-28, Volume: 50, Issue:1278

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Administration Schedule; Drug Interactions; Humans; Infusions, Intravenous; Pneumonia, Ventilator-Associated; Treatment Outcome; Urinary Tract Infections

2008
Activity of doripenem and comparator beta-lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin-binding domains of pbp1a, pbp2b and pbp2x.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:3

    Topics: Aminoacyltransferases; Bacterial Proteins; beta-Lactams; Carbapenems; Doripenem; Humans; Mutation; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Protein Structure, Tertiary; Streptococcus pneumoniae; United States

2008
Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Proteins; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Pseudomonas aeruginosa

2008
Quantification of doripenem in human plasma and peritoneal fluid by high-performance liquid chromatography with ultraviolet detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, May-01, Volume: 867, Issue:1

    Topics: Ascitic Fluid; Carbapenems; Chromatography, High Pressure Liquid; Doripenem; Humans; Reproducibility of Results; Spectrophotometry, Ultraviolet

2008
[Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
    The Japanese journal of antibiotics, 2007, Volume: 60, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Meropenem; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2007
Doripenem (doribax)--a new parenteral carbapenem.
    Obstetrics and gynecology, 2008, Volume: 111, Issue:5

    Topics: Carbapenems; Cross Infection; Doripenem; Female; Humans; Pneumonia; Pneumonia, Ventilator-Associated; Urinary Tract Infections

2008
In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Drug Resistance, Bacterial; Female; Humans; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections

2008
Compatibility of doripenem with other drugs during simulated Y-site administration.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Jul-01, Volume: 65, Issue:13

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Incompatibility; Injections, Intravenous; Nephelometry and Turbidimetry

2008
New drugs08, part 2.
    Nursing, 2008, Volume: 38, Issue:7

    Topics: Acromegaly; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Antineoplastic Agents; Biopterins; Carbapenems; Child; Child, Preschool; Cyclohexanes; Doripenem; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Epothilones; Humans; Infant; Maraviroc; Peptides, Cyclic; Pharmaceutical Preparations; Phenylketonurias; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Sirolimus; Somatostatin; Triazoles

2008
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Base Sequence; beta-Lactam Resistance; Carbapenems; DNA Primers; DNA, Bacterial; Doripenem; Fluoroquinolones; Genes, Bacterial; Humans; In Vitro Techniques; Meropenem; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2008
Pharmacodynamic assessment of doripenem in peritoneal fluid against Gram-negative organisms: use of population pharmacokinetic modeling and Monte Carlo simulation.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:3

    Topics: Adult; Algorithms; Anti-Bacterial Agents; Ascitic Fluid; Carbapenems; Doripenem; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Surgical Wound Infection; Young Adult

2008
Doripenem: a new carbapenem.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2008, Volume: 61, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans

2008
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; United States

2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests

2008
In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Doripenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

2009
In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

2009
Lucasti et al in the May 2008 issue of Clinical Therapeutics.
    Clinical therapeutics, 2008, Volume: 30, Issue:10

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Thienamycins

2008
Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Computer Simulation; Doripenem; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Plasma; Time Factors; Urine

2009
Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Clinical therapeutics, 2008, Volume: 30, Issue:11

    Topics: Anti-Bacterial Agents; Carbapenems; Chromatography, High Pressure Liquid; Cold Temperature; Dimerization; Doripenem; Drug Contamination; Drug Packaging; Drug Stability; Drug Storage; Glucose; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Injections; Molecular Structure; Particle Size; Pharmaceutical Solutions; Sodium Chloride; Time Factors

2008
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests

2009
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria, Aerobic; Carbapenems; Doripenem; Gram-Negative Bacterial Infections; Humans; Latin America; Microbial Sensitivity Tests; North America; Pseudomonas

2009
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Computer Simulation; Critical Illness; Doripenem; Female; Humans; Mice

2009
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests

2009
Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Enterococcus; Europe; Gram-Positive Bacterial Infections; Humans; Latin America; Microbial Sensitivity Tests; North America; Staphylococcus; Streptococcus

2009
In vitro activity of doripenem against Burkholderia pseudomallei.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Doripenem; Microbial Sensitivity Tests

2009
Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Encephalitis; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2009
Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Doripenem-induced intertriginous drug eruption as a mild form of AGEP.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:8

    Topics: Anti-Bacterial Agents; Axilla; Carbapenems; Doripenem; Epiglottitis; Exanthema; Groin; Humans; Leg; Male; Middle Aged

2009
In vitro activity of doripenem.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: Anti-Bacterial Agents; Carbapenems; Culture Media; Doripenem; Drug Therapy, Combination; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2009
Efficacy of intravenous infusion of doripenem.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated

2009
Safety of intravenous infusion of doripenem.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cross Infection; Doripenem; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Quality Control

2009
Clinical and economic consequences of ventilator-associated pneumonia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Health Care Costs; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Length of Stay; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Severity of Illness Index

2009
Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: beta-Lactamase Inhibitors; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2009
Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Utilization; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics as Topic; Thienamycins

2009
Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Health Facilities; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2009
In vivo efficacy of 1- and 2-gram human simulated prolonged infusions of doripenem against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Female; Humans; Mice; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Carbapenems; Doripenem; Enzyme Inhibitors; Hydrolysis; Imipenem; Kinetics; Meropenem; Microbial Sensitivity Tests; Thienamycins

2010
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation.
    Current medical research and opinion, 2010, Volume: 26, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Humans; Pneumonia; United States

2010
Pharmacokinetic/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem.
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Computer Simulation; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Pseudomonas aeruginosa

2010
The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem.
    Biochemistry, 2009, Dec-22, Volume: 48, Issue:50

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Carboxylic Acids; Catalytic Domain; Crystallization; Crystallography, X-Ray; Doripenem; Enzyme Stability; Ligands; Models, Molecular

2009
The changing face of antibiotic therapy.
    British journal of hospital medicine (London, England : 2005), 2009, Volume: 70, Issue:10

    Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Delayed-Action Preparations; Doripenem; Drug Resistance, Bacterial; Humans; Infection Control; Treatment Outcome

2009
Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:1

    Topics: Aged; Aged, 80 and over; Carbapenems; Critical Illness; Doripenem; Female; Half-Life; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Renal Insufficiency

2010
Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
    Journal of medical economics, 2010, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Cost-Benefit Analysis; Decision Support Techniques; Doripenem; Hospitalization; Humans; Imipenem; Intensive Care Units; Length of Stay; Middle Aged; Models, Economic; Monte Carlo Method; Pneumonia, Ventilator-Associated; Probability; Respiration, Artificial; Time Factors; United States

2010
Stability of meropenem and doripenem solutions for administration by continuous infusion.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Stability; Humans; Infusions, Intravenous; Meropenem; Solutions; Thienamycins

2010
Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Carbapenems; Chromatography; Doripenem; Humans; Infusions, Intravenous; Male; Middle Aged; Prostate; Prostatectomy; Serum

2010
Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections

2010
[Activity of doripenem against Pseudomonas spp. and Acinetobacter spp. rods].
    Medycyna doswiadczalna i mikrobiologia, 2009, Volume: 61, Issue:4

    Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Pseudomonas; Species Specificity

2009
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence

2010
Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Mutation; Porins; Proportional Hazards Models; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors

2010
Mutant prevention concentrations of four carbapenems against gram-negative rods.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Phenotype; Pseudomonas aeruginosa; Thienamycins

2010
Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.
    Pharmacotherapy, 2010, Volume: 30, Issue:4

    Topics: Acinetobacter baumannii; beta-Lactamases; Carbapenems; Doripenem; Genotype; Hospitals; Humans; Imipenem; Meropenem; Oxytocin; Polymerase Chain Reaction; Thienamycins

2010
Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
    Biochemistry, 2010, May-04, Volume: 49, Issue:17

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Cyclotrons; Doripenem; Ertapenem; Fourier Analysis; Hydrogen Bonding; Indicators and Reagents; Kinetics; Mass Spectrometry; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Protein Conformation

2010
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin

2010
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method

2010
Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators.
    Critical care (London, England), 2010, Volume: 14, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Female; Health Resources; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Prospective Studies; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome

2010
Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing method.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Doripenem; European Union; Humans; Microbial Sensitivity Tests

2010
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2010
[Activity of doripenem against anaerobic bacteria].
    Pathologie-biologie, 2011, Volume: 59, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Imipenem; Microbial Sensitivity Tests

2011
Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests

2010
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome

2010
The UV-derivative spectrophotometry for the determination of doripenem in the presence of its degradation products.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2010, Oct-01, Volume: 77, Issue:2

    Topics: Calibration; Carbapenems; Doripenem; Limit of Detection; Molecular Structure; Pharmaceutical Preparations; Solutions; Spectrophotometry, Ultraviolet; Water

2010
In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase- producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Immunocompetence; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Thigh

2010
Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia.
    Surgical infections, 2010, Volume: 11, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost-Benefit Analysis; Doripenem; Drug Combinations; Humans; Imipenem; Length of Stay; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Young Adult

2010
Stability of doripenem, imipenem and meropenem at elevated room temperatures.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Stability; Drug Storage; Imipenem; Meropenem; Temperature; Thienamycins; Time Factors

2011
Antimicrobial activity of doripenem against bacterial isolates from humans and animals.
    The Journal of antibiotics, 2010, Volume: 63, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Humans; Microbial Sensitivity Tests; Portugal

2010
Stability of doripenem in polyvinyl chloride bags and elastomeric pumps.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Sep-15, Volume: 67, Issue:18

    Topics: Anti-Bacterial Agents; Carbapenems; Chemical Precipitation; Doripenem; Drug Packaging; Drug Stability; Drug Storage; Elastomers; Freezing; Glucose; Humans; Pharmaceutical Vehicles; Polyvinyl Chloride; Refrigeration; Sodium Chloride; Temperature; Time Factors

2010
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3

    Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins

2010
Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Blood; Carbapenems; Disease Models, Animal; Doripenem; Female; Imipenem; Infusions, Intravenous; Lung; Meropenem; Plasma; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Spleen; Thienamycins; Treatment Outcome

2010
In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:6

    Topics: Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pacific Islands; Thienamycins

2010
Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Korea; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Thienamycins; Urinary Tract Infections

2011
In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Male; Meropenem; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Specific Pathogen-Free Organisms; Thienamycins

2011
Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-01, Volume: 51, Issue:11

    Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa

2010
Nosocomial infections: new therapeutic alternatives.
    Expert review of anti-infective therapy, 2010, Volume: 8, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic

2010
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Carbapenems; Cytokines; Disease Models, Animal; Doripenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Treatment Outcome

2011
Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:3

    Topics: Anti-Bacterial Agents; Asia; Australia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Thienamycins

2011
In vitro activity of doripenem against Burkholderia cepacia complex isolates from non-cystic fibrosis patients.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Carbapenems; Doripenem; Humans; Microbial Sensitivity Tests

2011
Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.
    Journal of molecular biology, 2011, Mar-04, Volume: 406, Issue:4

    Topics: Acinetobacter baumannii; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Crystallography, X-Ray; Doripenem; Models, Molecular; Mutant Proteins; Mutation, Missense; Protein Structure, Tertiary

2011
Potential interaction between valproic acid and doripenem.
    Current drug safety, 2011, Feb-01, Volume: 6, Issue:1

    Topics: Adolescent; Carbapenems; Doripenem; Drug Interactions; Female; Humans; Valproic Acid

2011
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa

2011
Determination of doripenem and related substances in medicinal product using capillary electrophoresis.
    Journal of separation science, 2011, Volume: 34, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Electrophoresis, Capillary; Pharmaceutical Preparations

2011
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States

2011
Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Microbial Sensitivity Tests; Minocycline; Nocardia; Quinolones; RNA, Ribosomal, 16S; Tigecycline

2011
Comparative activity of carbapenem testing: the COMPACT study.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5

    Topics: Africa; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle East; Thienamycins

2011
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.
    Infection control and hospital epidemiology, 2011, Volume: 32, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins

2011
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Burkholderia pseudomallei; Carbapenems; Doripenem; Ertapenem; Fluoroquinolones; Humans; Melioidosis; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline

2011
The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Edetic Acid; Humans; Imipenem; Laboratories; Meropenem; Microbial Sensitivity Tests; Netherlands; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Thienamycins

2011
Removal of doripenem during hemodialysis and the optimum dosing regimen for patients undergoing hemodialysis.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2011, Volume: 15, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis

2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey

2011
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Plasmids; Population Surveillance; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Spain; Thienamycins

2011
Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genotype; Imipenem; Klebsiella pneumoniae; Longitudinal Studies; Meropenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Thienamycins; United States

2011
Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

2011
In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:3

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Streptococcus pneumoniae; Thienamycins

2011
Effect of hemopurification rate on doripenem pharmacokinetics in critically ill patients receiving high-flow continuous hemodiafiltration.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2011, Volume: 131, Issue:9

    Topics: Aged; Aged, 80 and over; Carbapenems; Chromatography, High Pressure Liquid; Critical Illness; Doripenem; Female; Hemodiafiltration; Humans; Kidney Diseases; Male; Middle Aged; Severity of Illness Index; Time Factors

2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Half-Life; Humans; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections

2011
Evaluation of doripenem utilization and susceptibilities at a large urban hospital.
    International journal of clinical pharmacy, 2011, Volume: 33, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Failure; Treatment Outcome; Urban Health Services; Young Adult

2011
[In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2011, Volume: 64, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin

2011
Two cases of peritonsillar abscess complicated by von Willebrand disease.
    Auris, nasus, larynx, 2012, Volume: 39, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Coagulants; Doripenem; Factor VIII; Female; Humans; Male; Middle Aged; Peritonsillar Abscess; Tonsillectomy; von Willebrand Disease, Type 2; von Willebrand Diseases; Young Adult

2012
Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Chromatography, High Pressure Liquid; Doripenem; Extracellular Fluid; Humans; Infusions, Intravenous; Male; Microdialysis; Muscle, Skeletal; Plasma; Saliva; Subcutaneous Fat; Tandem Mass Spectrometry; Tissue Distribution

2012
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome

2012
Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Humans; Imipenem; Lung; Meropenem; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Thienamycins; Treatment Outcome

2012
Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Models, Biological; Mutation; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2012
Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 2012, Volume: 72, Issue:3

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Reference Standards; Thienamycins

2012
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins

2012
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors

2012
Penetration of doripenem in human brain: an observational microdialysis study in patients with acute brain injury.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Brain; Brain Injuries; Carbapenems; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Microdialysis; Middle Aged; Plasma; Time Factors

2012
Successful treatment with doripenem of ventriculitis due to Achromobacter xylosoxidans.
    QJM : monthly journal of the Association of Physicians, 2014, Volume: 107, Issue:11

    Topics: Achromobacter denitrificans; Adult; Anti-Bacterial Agents; Carbapenems; Cerebral Ventriculitis; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Treatment Outcome

2014
The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Combinations; Drug Interactions; Klebsiella pneumoniae; Microbial Sensitivity Tests

2012
Class A carbapenemase FPH-1 from Francisella philomiragia.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Doripenem; Ertapenem; Escherichia coli; Francisella; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam; Thienamycins

2012
Pharmacokinetics of doripenem in CSF of patients with non-inflamed meninges.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Doripenem; Humans; Models, Statistical; Plasma

2012
Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Animals; beta-Lactams; Carbapenems; Cell Line; Doripenem; Ertapenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Salmonella; Thienamycins

2012
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic

2012
Modeling approach to characterize intraocular doripenem pharmacokinetics after intravenous administration to rabbits, with tentative extrapolation to humans.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7

    Topics: Animals; Aqueous Humor; Carbapenems; Doripenem; Humans; Infusions, Intravenous; Rabbits; Vitreous Body

2012
Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic-pharmacodynamic evaluation.
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Carbapenems; Computer Simulation; Doripenem; Humans; Male; Microbial Sensitivity Tests; Monte Carlo Method; Prostate; Prostatitis; Tissue Distribution

2012
Pharmacodynamics of the antibacterial effect of and emergence of resistance to doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an in vitro pharmacokinetic model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Doripenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Synergism; Klebsiella pneumoniae; Microbial Sensitivity Tests

2012
OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem.
    Journal of enzyme inhibition and medicinal chemistry, 2013, Volume: 28, Issue:5

    Topics: beta-Lactamases; Biocatalysis; Carbapenems; Cloning, Molecular; DNA Transposable Elements; Doripenem; Drug Resistance, Bacterial; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Meropenem; Models, Molecular; Plasmids; Thienamycins

2013
Doripenem: excess mortality.
    Prescrire international, 2012, Volume: 21, Issue:130

    Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Early Termination of Clinical Trials; Evidence-Based Medicine; Humans; Imipenem; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome

2012
[Septic shock following flexible transurethral lithotripsy showing favourable response after multidisciplinary treatment mainly composed of recombinant thrombomodulin : a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2012, Volume: 58, Issue:9

    Topics: Aged; Carbapenems; Combined Modality Therapy; Doripenem; Female; Humans; Lithotripsy; Recombinant Proteins; Shock, Septic; Thrombomodulin; Treatment Outcome

2012
Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study.
    International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:1

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Carbapenems; Cholangitis; Doripenem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2013
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2012, Volume: 45, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins

2012
Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pacific Islands; Thienamycins; Time Factors

2013
Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Time Factors

2013
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors

2012
The use of UV, FT-IR and Raman spectra for the identification of the newest penem analogs: solutions based on mathematic procedure and the density functional theory.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Feb-15, Volume: 103

    Topics: beta-Lactams; Carbapenems; Doripenem; Models, Molecular; Quantum Theory; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thienamycins

2013
Comparison of in vitro activity of doripenem, imipenem and meropenem against clinical isolates of Enterobacteriaceae, Pseudomonas and Acinetobacter in Southern Poland.
    Polski przeglad chirurgiczny, 2012, Volume: 84, Issue:9

    Topics: Acinetobacter; Acinetobacter baumannii; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Doripenem; Enterobacteriaceae; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Poland; Pseudomonas; Species Specificity; Sputum; Thienamycins

2012
KPC presence in Pseudomonas aeruginosa has minimal impact on the in vivo efficacy of carbapenem therapy.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2013
Efficacy and safety of doripenem for sepsis with neutropenia in Japanese patients with hematologic diseases.
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Liver; Male; Middle Aged; Neutropenia; Prospective Studies; Sepsis

2012
Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:5

    Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Imipenem; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Monobactams; Pseudomonas aeruginosa; Thiazoles; Thienamycins

2013
Prolonged infusion of carbapenems in critically ill patients: time to extend our practice.
    Critical care medicine, 2013, Volume: 41, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Doripenem; Female; Humans; Male; Obesity; Pneumonia, Bacterial

2013
Pharmacodynamic variability beyond that explained by MICs.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Carbapenems; Doripenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Thigh

2013
Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Larva; Lipid A; Microbial Sensitivity Tests; Moths; Signal Transduction; Vancomycin

2013
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Ertapenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Treatment Outcome

2013
In vitro activity of doripenem plus fosfomycin against drug-resistant clinical blood isolates.
    Pharmacology, 2013, Volume: 91, Issue:3-4

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests

2013
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome

2013
Pharmacokinetics of doripenem in infected patients treated within and outside the intensive care unit.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Body Mass Index; Carbapenems; Creatinine; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method

2013
[In vitro activity of doripenem against strains from pediatric diseases and strains causing purulent meningitis].
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:6

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Child; Doripenem; Haemophilus influenzae; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Streptococcus pneumoniae; Suppuration

2012
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin

2013
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Microbial drug resistance (Larchmont, N.Y.), 2013, Volume: 19, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline

2013
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.
    Pediatric pulmonology, 2014, Volume: 49, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2014
Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:2

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chromatography, Liquid; Cross Infection; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Plasma; Pneumonia, Bacterial; Tandem Mass Spectrometry; Time Factors

2013
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Minocycline; Models, Theoretical; Sulbactam; Tigecycline

2013
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Time Factors

2013
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.
    Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis

2013
When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents.
    Clinical therapeutics, 2013, Volume: 35, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Drug Costs; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2013
In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients.
    Advances in experimental medicine and biology, 2013, Volume: 788

    Topics: Acinetobacter baumannii; Bacterial Infections; Carbapenems; Doripenem; Electrophoresis, Gel, Pulsed-Field; Europe; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity; Species Specificity; Thienamycins; United States; United States Food and Drug Administration

2013
IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Hydrophobic and Hydrophilic Interactions; Imipenem; Japan; Meropenem; Phylogeny; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship; Thienamycins

2013
Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Acinetobacter; Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Crystallography, X-Ray; Doripenem; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid

2013
Effect of pulmonary surfactant on antimicrobial activity in vitro.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Carbapenems; Colistin; Daptomycin; Doripenem; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Oxazolidinones; Pulmonary Surfactants; Quinolines; Staphylococcus aureus; Swine; Tigecycline

2013
Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multivariate Analysis; Mutation; Porins; Promoter Regions, Genetic

2013
In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Antitubercular Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Wall; Clavulanic Acid; Doripenem; Enzyme Assays; Ertapenem; Escherichia coli; Gene Expression; Imipenem; Kinetics; Meropenem; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Recombinant Proteins; Thienamycins

2013
Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Meningoencephalitis; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Surgical Wound Infection; Treatment Outcome

2014
Pseudohemoptysis due to Serratia marcescens.
    Journal of general internal medicine, 2014, Volume: 29, Issue:6

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Diagnosis, Differential; Doripenem; Hemoptysis; Humans; Male; Serratia Infections; Serratia marcescens; Sputum; Treatment Outcome

2014
In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Sulbactam

2014
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2014
Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Disease Models, Animal; Doripenem; Ertapenem; Humans; Klebsiella pneumoniae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2014
[Case report; a case of lung and skin nocardiosis in a non-immunocompromised patient].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2013, Oct-10, Volume: 102, Issue:10

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Diagnosis, Differential; Doripenem; Drainage; Humans; Male; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Radiography, Thoracic; Skin Diseases, Bacterial; Sputum; Suppuration; Tomography, X-Ray Computed

2013
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Algorithms; Anti-Bacterial Agents; Aspartic Acid; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Genotype; Gentamicins; Glycine; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Porins

2014
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Plasmids

2014
Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device.
    Transplantation proceedings, 2014, Volume: 46, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Carbapenems; Doripenem; Female; Heart-Assist Devices; Humans; Male; Retrospective Studies; Teicoplanin; Wounds and Injuries

2014
[Studies on the distribution of doripenem in pancreatic tissues, especially on the importance of the ratio in pancreatic tissue concentration of doripenem/serum concentration of doripenem].
    The Japanese journal of antibiotics, 2014, Volume: 67, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Doripenem; Humans; Pancrelipase

2014
Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9

    Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Colony Count, Microbial; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors

2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Plasma; Young Adult

2014
Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Acinetobacter baumannii; Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Doripenem; Enterobacteriaceae; Fosfomycin; Humans; Meropenem; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pakistan; Thienamycins

2014
Crystal chemistry of the antibiotic doripenem.
    Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:11

    Topics: Anti-Bacterial Agents; Calorimetry, Differential Scanning; Carbapenems; Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Doripenem; Hydrogen Bonding; Models, Molecular; Molecular Structure; Powder Diffraction; Technology, Pharmaceutical; Temperature; Thermogravimetry; Water

2014
The doripenem serum concentrations in intensive care patients suffering from acute kidney injury, sepsis, and multi organ dysfunction syndrome undergoing continuous renal replacement therapy slow low-efficiency dialysis.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Carbapenems; Critical Care; Doripenem; Humans; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Renal Dialysis; Sepsis

2014
Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Doripenem; Microbial Sensitivity Tests; Models, Statistical

2015
[A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital].
    The Japanese journal of antibiotics, 2014, Volume: 67, Issue:4

    Topics: Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2014
Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases.
    Biochemistry, 2015, Jan-20, Volume: 54, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Doripenem; Ertapenem; Escherichia coli; Kinetics; Meropenem; Models, Molecular; Thienamycins

2015
Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Computer Simulation; Doripenem; Humans; Japan; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method; Renal Insufficiency; Young Adult

2015
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.
    BioMed research international, 2014, Volume: 2014

    Topics: Carbapenems; Colistin; Doripenem; Dose-Response Relationship, Drug; Drug Combinations; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Minocycline; Rifampin; Tigecycline; Tobramycin

2014
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Retrospective Studies

2015
The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Gene Expression Profiling; Models, Theoretical; Sequence Analysis, RNA; Time Factors

2015
Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colony Count, Microbial; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Microbial Sensitivity Tests; Mutation Rate; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; RNA, Messenger

2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Pseudomonas aeruginosa; Time Factors

2015
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
    The new microbiologica, 2015, Volume: 38, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline

2015
[Pharmacokinetics study of injected doripenemin healthy volunteers].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2015, Volume: 46, Issue:1

    Topics: Carbapenems; Chromatography, High Pressure Liquid; Doripenem; Healthy Volunteers; Humans; Infusions, Intravenous; Meropenem; Thienamycins

2015
Prediction of Pharmacokinetics and Pharmacodynamics of Doripenem in Pediatric Patients.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Child; Doripenem; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Streptococcus pneumoniae

2015
Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen.
    International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Computer Simulation; Doripenem; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Computer-Assisted; Female; Humans; Kidney; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Pneumonia, Bacterial; Prospective Studies; Software; Thienamycins; Treatment Outcome

2015
Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Doripenem; Electrophoresis, Polyacrylamide Gel; Meropenem; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins

2015
Antimicrobial resistance surveillance of doripenem in China.
    The Journal of antibiotics, 2015, Volume: 68, Issue:8

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; China; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Epidemiological Monitoring; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa

2015
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Doripenem; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thienamycins

2015
IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11

    Topics: beta-Lactamases; Carbapenems; Cefoxitin; Doripenem; Escherichia coli; Meropenem; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins

2015
Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India.
    Journal of infection in developing countries, 2015, Aug-29, Volume: 9, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Tigecycline

2015
In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross-Sectional Studies; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2015
Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Prospective Studies; Pseudomonas aeruginosa; Sepsis; Survival Analysis

2016
Quantitative determination of the β-methyl carbapenem doripenem in powder for injection by a stability-indicating capillary zone electrophoresis method.
    Die Pharmazie, 2015, Volume: 70, Issue:9

    Topics: Anti-Bacterial Agents; Carbapenems; Chromatography, High Pressure Liquid; Doripenem; Drug Stability; Electrophoresis, Capillary; Injections; Limit of Detection; Powders; Reference Standards; Reproducibility of Results

2015
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
    Critical care (London, England), 2015, Dec-15, Volume: 19

    Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin

2015
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Annals of laboratory medicine, 2016, Volume: 36, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline

2016
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
    Xenobiotica; the fate of foreign compounds in biological systems, 2016, Volume: 46, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin

2016
Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates.
    Saudi medical journal, 2016, Volume: 37, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Thienamycins

2016
[Analysis of carbapenems by hydrophilic interaction chromatography and its application].
    Se pu = Chinese journal of chromatography, 2015, Volume: 33, Issue:9

    Topics: beta-Lactams; Carbapenems; Chromatography; Doripenem; Drinking Water; Ertapenem; Humans; Hydrophobic and Hydrophilic Interactions; Meropenem; Thienamycins

2015
Clinical efficacy and safety of high-dose doripenem in Japanese patients with pneumonia.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Japan; Male; Pneumonia, Bacterial; Prospective Studies; Sputum; Treatment Outcome

2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Doripenem; Drug Synergism; Microbial Sensitivity Tests; Mutation; Polymyxin B; Pseudomonas aeruginosa

2016
MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.
    The Journal of antibiotics, 2016, Volume: 69, Issue:11

    Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2016
Comparative In Vitro Efficacy of Doripenem and Imipenem Against Multi-Drug Resistant Pseudomonas aeruginosa.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016, Volume: 26, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Cross-Sectional Studies; Doripenem; Drug Resistance, Multiple; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2016
Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; beta-Lactamases; Captopril; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Doripenem; Imipenem; Meropenem; Mesna; Protein Structure, Secondary; Protein Structure, Tertiary; Serratia marcescens; Thienamycins

2016
Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
    Journal of applied microbiology, 2016, Volume: 121, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Thienamycins

2016
Pyogenic vertebral osteomyelitis caused by Yersinia pseudotuberculosis.
    Joint bone spine, 2016, Volume: 83, Issue:6

    Topics: Aged; Blood Culture; Carbapenems; Clindamycin; Discitis; Doripenem; Drug Therapy, Combination; Fever; Follow-Up Studies; Humans; Infusions, Intravenous; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Osteomyelitis; Rare Diseases; Thoracic Vertebrae; Treatment Outcome; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections

2016
Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Thienamycins; Treatment Outcome

2016
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis.
    Japanese journal of infectious diseases, 2017, Mar-24, Volume: 70, Issue:2

    Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam

2017
In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.
    The Journal of antibiotics, 2017, Volume: 70, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline

2017
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    BMC infectious diseases, 2016, 08-24, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Taiwan; Thienamycins

2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Clinical therapeutics, 2016, Volume: 38, Issue:9

    Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam

2016
The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.
    Protein science : a publication of the Protein Society, 2016, Volume: 25, Issue:12

    Topics: Acinetobacter baumannii; Amino Acid Substitution; beta-Lactamases; Binding Sites; Carbapenems; Crystallography, X-Ray; Doripenem; Molecular Dynamics Simulation; Mutation, Missense

2016
Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis.
    Surgical infections, 2016, Volume: 17, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Wounds and Injuries

2016
Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cross Infection; Doripenem; Female; Hospital Mortality; Humans; Intraabdominal Infections; Male; Middle Aged; Respiratory Tract Infections; Retrospective Studies; Soft Tissue Infections; Tertiary Care Centers; Treatment Outcome; Urinary Tract Infections

2016
Maculopapular eruption caused by doripenem.
    European journal of dermatology : EJD, 2017, 04-01, Volume: 27, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Eruptions; Exanthema; Humans; Male; Middle Aged; Pneumonia

2017
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States

2017
Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized Patients.
    The Annals of pharmacotherapy, 2017, Volume: 51, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Body Weight; Carbapenems; Doripenem; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Obesity

2017
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins

2017
Pharmacokinetic/Pharmacodynamic Analysis for Doripenem Regimens in Intensive Care Unit Patient.
    Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Carbapenems; Doripenem; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Prostatitis; Urinary Tract Infections; Young Adult

2017
Investigation of genotoxic effects of doripenem using cytogenetic and molecular methods.
    Cellular and molecular biology (Noisy-le-Grand, France), 2017, Oct-31, Volume: 63, Issue:10

    Topics: Anti-Bacterial Agents; Carbapenems; Cell Nucleus; Cells, Cultured; Chromosome Aberrations; Doripenem; Genomic Instability; Humans; Lymphocytes; Micronucleus Tests; Random Amplified Polymorphic DNA Technique

2017
Multiple substitutions lead to increased loop flexibility and expanded specificity in
    The Biochemical journal, 2018, 01-11, Volume: 475, Issue:1

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cloning, Molecular; Crystallography, X-Ray; Doripenem; Escherichia coli; Gene Expression; Genetic Vectors; Imipenem; Kinetics; Models, Molecular; Mutation; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity

2018
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
    Medecine et maladies infectieuses, 2018, Volume: 48, Issue:5

    Topics: beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Reagent Strips; Sensitivity and Specificity

2018
Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Doripenem; Hydrophobic and Hydrophilic Interactions; Imipenem; Meropenem; Microbial Sensitivity Tests; Protein Structure, Secondary

2019
Molecular docking, dynamics and free energy analyses of
    Journal of medical microbiology, 2020, Volume: 69, Issue:8

    Topics: Acinetobacter baumannii; Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Computer Simulation; Doripenem; Ertapenem; Hydrolysis; Meropenem; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation

2020
A method to quantify viable carbapenem resistant gram-negative bacteria in treated and untreated wastewater.
    Journal of microbiological methods, 2020, Volume: 179

    Topics: Anti-Bacterial Agents; Bacterial Load; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Ertapenem; Imipenem; Meropenem; Wastewater; Water Purification

2020
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
    Clinical biochemistry, 2021, Volume: 90

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole

2021
Auranofin promotes antibacterial effect of doripenem against carbapenem-resistant Acinetobacter baumannii.
    Journal of applied microbiology, 2022, Volume: 133, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Auranofin; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests

2022
Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.
    The American journal of tropical medicine and hygiene, 2022, 08-17, Volume: 107, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Doripenem; Escherichia coli; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Taiwan; Tertiary Care Centers

2022
Carbapenem resistance gene crisis in A. baumannii: a computational analysis.
    BMC microbiology, 2022, 12-03, Volume: 22, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Doripenem; Imipenem; Meropenem; Molecular Docking Simulation

2022
Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii.
    Microbial pathogenesis, 2023, Volume: 177

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenems; Doripenem; Ertapenem; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Porins

2023
Risk evaluation of carbapenem-induced liver injury based on machine learning analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:7

    Topics: Anti-Bacterial Agents; Carbapenems; Chemical and Drug Induced Liver Injury, Chronic; Doripenem; Humans; Meropenem

2023
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Doripenem; Humans; Imipenem; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023